Tanguler Tolga Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
11
Insider Sells Sum
$2.94M

Insider Activity of Tanguler Tolga

According to the SEC Form 4 filings, Tanguler Tolga, being in a position of

  1. EVP, Chief Commercial Officer at Alnylam Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 7376 shares for $2.42M,
    over all time since 2022-07-05, has bought 0 shares, and sold 27579 shares for $8.19M.

Biography of Tanguler Tolga

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $2,424,9434100

Comparison of Insiders on Amount of Buys and Sells

2026-03-04SaleAlnylam Pharmaceuticals, Inc.
ALNY
EVP, Chief Commercial Officer
2,309
0.0017%
$323.08$745,984-12.54%
2026-03-02SaleAlnylam Pharmaceuticals, Inc.
ALNY
EVP, Chief Commercial Officer
1,598
0.0012%
$327.65$523,584-11.89%
2026-02-13SaleAlnylam Pharmaceuticals, Inc.
ALNY
EVP, Chief Commercial Officer
1,959
0.0015%
$310.08$607,448-8.34%
2026-01-12SaleAlnylam Pharmaceuticals, Inc.
ALNY
EVP, Chief Commercial Officer
1,510
0.0011%
$362.87$547,927-20.79%
2025-10-02SaleAlnylam Pharmaceuticals, Inc.
ALNY
EVP, Chief Commercial Officer
1,405
0.0011%
$452.05$635,126-31.16%
2025-08-29SaleAlnylam Pharmaceuticals, Inc.
ALNY
EVP, Chief Commercial Officer
3,474
0.0027%
$448.37$1.56M-26.51%
2025-08-18SaleAlnylam Pharmaceuticals, Inc.
ALNY
EVP, Chief Commercial Officer
1,396
0.0011%
$453.27$632,759-27.2%
2025-03-03SaleAlnylam Pharmaceuticals, Inc.
ALNY
EVP, Chief Commercial Officer
471
0.0004%
$243.78$114,820+44.46%
2025-02-28SaleAlnylam Pharmaceuticals, Inc.
ALNY
EVP, Chief Commercial Officer
513
0.0004%
$241.68$123,983+42.61%
2024-11-26SaleAlnylam Pharmaceuticals, Inc.
ALNY
EVP, Chief Commercial Officer
1,469
0.0011%
$250.98$368,686+18.3%
2024-06-25SaleAlnylam Pharmaceuticals, Inc.
ALNY
EVP, Chief Commercial Officer
1,605
0.0012%
$231.00$370,747+9.36%
2024-02-28SaleAlnylam Pharmaceuticals, Inc.
ALNY
EVP, Chief Commercial Officer
501
0.0004%
$155.30$77,805+58.99%
2024-02-16SaleAlnylam Pharmaceuticals, Inc.
ALNY
EVP, Chief Commercial Officer
1,009
0.0008%
$148.06$149,397+66.97%
2023-04-27SaleAlnylam Pharmaceuticals, Inc.
ALNY
EVP, Chief Commercial Officer
1,476
0.0012%
$194.59$287,215-8.12%
2023-02-03SaleAlnylam Pharmaceuticals, Inc.
ALNY
EVP, Chief Commercial Officer
3,424
0.0027%
$232.14$794,854-18.53%
2023-02-02SaleAlnylam Pharmaceuticals, Inc.
ALNY
EVP, Chief Commercial Officer
1,601
0.0013%
$226.01$361,839-17.23%
2022-08-03SaleAlnylam Pharmaceuticals, Inc.
ALNY
EVP, Chief Commercial Officer
105
<0.0001%
$220.95$23,200-3.42%
2022-07-05SaleAlnylam Pharmaceuticals, Inc.
ALNY
EVP, Chief Commercial Officer
1,754
0.0014%
$150.00$263,100+35.68%
Total: 18
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.